Cargando…
Effects of CXCL12 isoforms in a pancreatic pre-tumour cellular model: Microarray analysis
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of death among cancers, it is characterized by poor prognosis and strong chemoresistance. In the PDAC microenvironment, stromal cells release different extracellular components, including CXCL12. The CXCL12 is a chemokin...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058651/ https://www.ncbi.nlm.nih.gov/pubmed/33958847 http://dx.doi.org/10.3748/wjg.v27.i15.1616 |
_version_ | 1783681052328329216 |
---|---|
author | Cecati, Monia Giulietti, Matteo Righetti, Alessandra Sabanovic, Berina Piva, Francesco |
author_facet | Cecati, Monia Giulietti, Matteo Righetti, Alessandra Sabanovic, Berina Piva, Francesco |
author_sort | Cecati, Monia |
collection | PubMed |
description | BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of death among cancers, it is characterized by poor prognosis and strong chemoresistance. In the PDAC microenvironment, stromal cells release different extracellular components, including CXCL12. The CXCL12 is a chemokine promoting the communication between tumour and stromal cells. Six different splicing isoforms of CXCL12 are known (α, β, γ, δ, ε, θ) but their role in PDAC has not yet been characterized. AIM: To investigate the specific role of α, β, and γ CXCL12 isoforms in PDAC onset. METHODS: We used hTERT-HPNE E6/E7/KRasG12D (Human Pancreatic Nestin-Expressing) cell line as a pancreatic pre-tumour model and exposed it to the α, β, and γ CXCL12 isoforms. The altered expression profiles were assessed by microarray analyses and confirmed by Real-Time polymerase chain reaction. The functional enrichment analyses have been performed by Enrichr tool to highlight Gene Ontology enriched terms. In addition, wound healing assays have been carried out to assess the phenotypic changes, in terms of migration ability, induced by the α, β, and γ CXCL12 isoforms. RESULTS: Microarray analysis of hTERT-HPNE cells treated with the three different CXCL12 isoforms highlighted that the expression of only a few genes was altered. Moreover, the α and β isoforms showed an alteration in expression of different genes, whereas γ isoform affected the expression of genes also common with α and β isoforms. The β isoform altered the expression of genes mainly involved in cell cycle regulation. In addition, all isoforms affected the expression of genes associated to cell migration, adhesion and cytoskeleton. In vitro cell migration assay confirmed that CXCL12 enhanced the migration ability of hTERT-HPNE cells. Among the CXCL12 splicing isoforms, the γ isoform showed higher induction of migration than α and β isoforms. CONCLUSION: Our data suggests an involvement and different roles of CXCL12 isoforms in PDAC onset. However, more investigations are needed to confirm these preliminary observations. |
format | Online Article Text |
id | pubmed-8058651 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-80586512021-05-05 Effects of CXCL12 isoforms in a pancreatic pre-tumour cellular model: Microarray analysis Cecati, Monia Giulietti, Matteo Righetti, Alessandra Sabanovic, Berina Piva, Francesco World J Gastroenterol Basic Study BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of death among cancers, it is characterized by poor prognosis and strong chemoresistance. In the PDAC microenvironment, stromal cells release different extracellular components, including CXCL12. The CXCL12 is a chemokine promoting the communication between tumour and stromal cells. Six different splicing isoforms of CXCL12 are known (α, β, γ, δ, ε, θ) but their role in PDAC has not yet been characterized. AIM: To investigate the specific role of α, β, and γ CXCL12 isoforms in PDAC onset. METHODS: We used hTERT-HPNE E6/E7/KRasG12D (Human Pancreatic Nestin-Expressing) cell line as a pancreatic pre-tumour model and exposed it to the α, β, and γ CXCL12 isoforms. The altered expression profiles were assessed by microarray analyses and confirmed by Real-Time polymerase chain reaction. The functional enrichment analyses have been performed by Enrichr tool to highlight Gene Ontology enriched terms. In addition, wound healing assays have been carried out to assess the phenotypic changes, in terms of migration ability, induced by the α, β, and γ CXCL12 isoforms. RESULTS: Microarray analysis of hTERT-HPNE cells treated with the three different CXCL12 isoforms highlighted that the expression of only a few genes was altered. Moreover, the α and β isoforms showed an alteration in expression of different genes, whereas γ isoform affected the expression of genes also common with α and β isoforms. The β isoform altered the expression of genes mainly involved in cell cycle regulation. In addition, all isoforms affected the expression of genes associated to cell migration, adhesion and cytoskeleton. In vitro cell migration assay confirmed that CXCL12 enhanced the migration ability of hTERT-HPNE cells. Among the CXCL12 splicing isoforms, the γ isoform showed higher induction of migration than α and β isoforms. CONCLUSION: Our data suggests an involvement and different roles of CXCL12 isoforms in PDAC onset. However, more investigations are needed to confirm these preliminary observations. Baishideng Publishing Group Inc 2021-04-21 2021-04-21 /pmc/articles/PMC8058651/ /pubmed/33958847 http://dx.doi.org/10.3748/wjg.v27.i15.1616 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) |
spellingShingle | Basic Study Cecati, Monia Giulietti, Matteo Righetti, Alessandra Sabanovic, Berina Piva, Francesco Effects of CXCL12 isoforms in a pancreatic pre-tumour cellular model: Microarray analysis |
title | Effects of CXCL12 isoforms in a pancreatic pre-tumour cellular model: Microarray analysis |
title_full | Effects of CXCL12 isoforms in a pancreatic pre-tumour cellular model: Microarray analysis |
title_fullStr | Effects of CXCL12 isoforms in a pancreatic pre-tumour cellular model: Microarray analysis |
title_full_unstemmed | Effects of CXCL12 isoforms in a pancreatic pre-tumour cellular model: Microarray analysis |
title_short | Effects of CXCL12 isoforms in a pancreatic pre-tumour cellular model: Microarray analysis |
title_sort | effects of cxcl12 isoforms in a pancreatic pre-tumour cellular model: microarray analysis |
topic | Basic Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058651/ https://www.ncbi.nlm.nih.gov/pubmed/33958847 http://dx.doi.org/10.3748/wjg.v27.i15.1616 |
work_keys_str_mv | AT cecatimonia effectsofcxcl12isoformsinapancreaticpretumourcellularmodelmicroarrayanalysis AT giuliettimatteo effectsofcxcl12isoformsinapancreaticpretumourcellularmodelmicroarrayanalysis AT righettialessandra effectsofcxcl12isoformsinapancreaticpretumourcellularmodelmicroarrayanalysis AT sabanovicberina effectsofcxcl12isoformsinapancreaticpretumourcellularmodelmicroarrayanalysis AT pivafrancesco effectsofcxcl12isoformsinapancreaticpretumourcellularmodelmicroarrayanalysis |